<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02817087</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00014213</org_study_id>
    <nct_id>NCT02817087</nct_id>
  </id_info>
  <brief_title>Multifocal Brain Magnetic Stimulation in Chronic Ischemic Stroke</brief_title>
  <official_title>An Innovative Approach to Restoration of Function in Chronic Ischemic Stroke Using a New Wearable Multifocal Brain Stimulator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>David Chiu, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Methodist Hospital System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Methodist Hospital System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transcranial magnetic stimulation for post-stroke upper-body motor deficits.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study uses transcranial magnetic stimulation of brain motor areas to test whether
      upper-body motor function can be improved. This is a double-blind study where half of
      patients will receive real stimulation and half will receive sham (placebo) stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Active repetitive transcranial magnetic stimulation administered through cap worn by patient under healthcare provider.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double-blind, only the care provider is aware of active treatment assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Percent increase in number and mean intensity (mean T value) of activated voxels in the cortical areas surrounding the lesion on functional MRI</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Changes in brain activation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer motor arm score</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Changes in arm motor functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ARAT (Action Research Arm Test)</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Changes in arm and hand motor functioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand dynamometer</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Changes in grip strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pinch dynamometer score</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Changes in pinch strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go Test</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Changes in timed up-and-go time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Rankin Scale (mRS)</measure>
    <time_frame>One business day before treatment begins, one business day after treatment ends</time_frame>
    <description>Assessment of global disability</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Active treatment w/rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap and are provided ACTIVE treatment delivering transcranial magnetic stimulation; the cap's rTMS capability is on.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham treatment w/rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants wear the repetitive transcranial magnetic stimulation (rTMS) cap and are provided SHAM treatment not delivering any transcranial magnetic stimulation; the cap's rTMS capability is not turned on.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>repetitive Transcranial Magnetic Stimulation (TMS)</intervention_name>
    <description>Repetitive transcranial magnetic stimulation delivered through a cap to the scalp whereby the rTMS activity is on (active treatment) or off (sham treatment).</description>
    <arm_group_label>Active treatment w/rTMS</arm_group_label>
    <arm_group_label>Sham treatment w/rTMS</arm_group_label>
    <other_name>TMS</other_name>
    <other_name>transcranial magnetic stimulation</other_name>
    <other_name>Transcranial Rotating Permanment Magnet Stimulation (TRPMS)</other_name>
    <other_name>rTMS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged ≥ 18 years;

          -  Clinical diagnosis of chronic ischemic stroke recovering for more than 3 months with
             unilateral motor deficits of arm and leg, or arm alone; and

          -  Patients may be on medications for the treatment of stroke or comorbidities provided
             the medication regimen is stable for six weeks prior to inclusion in the study and
             remains unchanged for the duration of the study.

        Exclusion Criteria:

          -  History of seizure;

          -  Epileptogenic activity (indicative of increased risk of seizures) on EEG;

          -  Any active unstable medical condition;

          -  Pregnancy;

          -  Schizophrenia, bipolar disorder, alcoholism, or substance abuse;

          -  Medications which in the investigator's clinical judgment significantly lower the
             seizure threshold;

          -  Presence of metal or electronic implants in the body, including pacemakers,
             defibrillators, aneurysm clips, neuro-stimulators, cochlear implants, metal in the
             eyes, etc.; and

          -  Any changes in medications prescribed for the treatment of stroke or comorbiities six
             weeks prior to inclusion in the study or at any time during the study.

          -  Treatment with botulinum toxin in the two months prior to treatment or any planned
             treatment with botulinum toxin in the period of the treatment

          -  Neurological condition not stable - clinically significant changes in NIHSS,
             Fugl-Meyer score, or ARAT score between Visits 1 and 2 (treatment begins at Visit 3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Chiu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Methodist Hospital System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rehme AK, Grefkes C. Cerebral network disorders after stroke: evidence from imaging-based connectivity analyses of active and resting brain states in humans. J Physiol. 2013 Jan 1;591(1):17-31. doi: 10.1113/jphysiol.2012.243469. Epub 2012 Oct 22. Review.</citation>
    <PMID>23090951</PMID>
  </reference>
  <reference>
    <citation>Li W, Li Y, Zhu W, Chen X. Changes in brain functional network connectivity after stroke. Neural Regen Res. 2014 Jan 1;9(1):51-60. doi: 10.4103/1673-5374.125330.</citation>
    <PMID>25206743</PMID>
  </reference>
  <reference>
    <citation>Varsou O, Macleod MJ, Schwarzbauer C. Functional connectivity magnetic resonance imaging in stroke: an evidence-based clinical review. Int J Stroke. 2014 Feb;9(2):191-8. doi: 10.1111/ijs.12033. Epub 2013 Mar 19. Review.</citation>
    <PMID>23506092</PMID>
  </reference>
  <reference>
    <citation>Ameli M, Grefkes C, Kemper F, Riegg FP, Rehme AK, Karbe H, Fink GR, Nowak DA. Differential effects of high-frequency repetitive transcranial magnetic stimulation over ipsilesional primary motor cortex in cortical and subcortical middle cerebral artery stroke. Ann Neurol. 2009 Sep;66(3):298-309. doi: 10.1002/ana.21725.</citation>
    <PMID>19798637</PMID>
  </reference>
  <reference>
    <citation>Chang WH, Kim YH, Bang OY, Kim ST, Park YH, Lee PK. Long-term effects of rTMS on motor recovery in patients after subacute stroke. J Rehabil Med. 2010 Sep;42(8):758-64. doi: 10.2340/16501977-0590.</citation>
    <PMID>20809058</PMID>
  </reference>
  <reference>
    <citation>Kim YH, You SH, Ko MH, Park JW, Lee KH, Jang SH, Yoo WK, Hallett M. Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke. 2006 Jun;37(6):1471-6. Epub 2006 May 4. Erratum in: Stroke. 2006 Nov;37(11):2861.</citation>
    <PMID>16675743</PMID>
  </reference>
  <reference>
    <citation>Khedr EM, Etraby AE, Hemeda M, Nasef AM, Razek AA. Long-term effect of repetitive transcranial magnetic stimulation on motor function recovery after acute ischemic stroke. Acta Neurol Scand. 2010 Jan;121(1):30-7. doi: 10.1111/j.1600-0404.2009.01195.x. Epub 2009 Aug 11.</citation>
    <PMID>19678808</PMID>
  </reference>
  <reference>
    <citation>Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006 Dec;117(12):2584-96. Epub 2006 Aug 4. Review.</citation>
    <PMID>16890483</PMID>
  </reference>
  <reference>
    <citation>Fregni F, Boggio PS, Valle AC, Rocha RR, Duarte J, Ferreira MJ, Wagner T, Fecteau S, Rigonatti SP, Riberto M, Freedman SD, Pascual-Leone A. A sham-controlled trial of a 5-day course of repetitive transcranial magnetic stimulation of the unaffected hemisphere in stroke patients. Stroke. 2006 Aug;37(8):2115-22. Epub 2006 Jun 29.</citation>
    <PMID>16809569</PMID>
  </reference>
  <reference>
    <citation>Málly J, Dinya E. Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS). Brain Res Bull. 2008 Jul 1;76(4):388-95. doi: 10.1016/j.brainresbull.2007.11.019. Epub 2007 Dec 26.</citation>
    <PMID>18502315</PMID>
  </reference>
  <reference>
    <citation>Boggio PS, Alonso-Alonso M, Mansur CG, Rigonatti SP, Schlaug G, Pascual-Leone A, Fregni F. Hand function improvement with low-frequency repetitive transcranial magnetic stimulation of the unaffected hemisphere in a severe case of stroke. Am J Phys Med Rehabil. 2006 Nov;85(11):927-30.</citation>
    <PMID>17079967</PMID>
  </reference>
  <reference>
    <citation>Grefkes C, Nowak DA, Wang LE, Dafotakis M, Eickhoff SB, Fink GR. Modulating cortical connectivity in stroke patients by rTMS assessed with fMRI and dynamic causal modeling. Neuroimage. 2010 Mar;50(1):233-42. doi: 10.1016/j.neuroimage.2009.12.029. Epub 2009 Dec 18.</citation>
    <PMID>20005962</PMID>
  </reference>
  <reference>
    <citation>Helekar, S.A., et al., Electromyographic motor-evoked potentials elicited by transcranial magnetic stimulation with rapidly moving permanent magnets mounted on a multisite stimulator cap, in 2013 Neuroscience Meeting Planner. 2013, Society for Neuroscience: San Diego, CA.</citation>
  </reference>
  <reference>
    <citation>Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7(4):254-66.</citation>
    <PMID>10408769</PMID>
  </reference>
  <reference>
    <citation>Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002 Jan;15(1):273-89.</citation>
    <PMID>11771995</PMID>
  </reference>
  <reference>
    <citation>Bressler SL, Seth AK. Wiener-Granger causality: a well established methodology. Neuroimage. 2011 Sep 15;58(2):323-9. doi: 10.1016/j.neuroimage.2010.02.059. Epub 2010 Mar 2.</citation>
    <PMID>20202481</PMID>
  </reference>
  <reference>
    <citation>Matias FS, Gollo LL, Carelli PV, Bressler SL, Copelli M, Mirasso CR. Modeling positive Granger causality and negative phase lag between cortical areas. Neuroimage. 2014 Oct 1;99:411-8. doi: 10.1016/j.neuroimage.2014.05.063. Epub 2014 Jun 2.</citation>
    <PMID>24893321</PMID>
  </reference>
  <reference>
    <citation>Chen Y, Bressler SL, Ding M. Frequency decomposition of conditional Granger causality and application to multivariate neural field potential data. J Neurosci Methods. 2006 Jan 30;150(2):228-37. Epub 2005 Aug 15.</citation>
    <PMID>16099512</PMID>
  </reference>
  <reference>
    <citation>Blair RC, Karniski W. An alternative method for significance testing of waveform difference potentials. Psychophysiology. 1993 Sep;30(5):518-24.</citation>
    <PMID>8416078</PMID>
  </reference>
  <reference>
    <citation>Chiavarini M, Morini G, Barocelli E, Bordi F, Plazzi PV, Vitali T, Impicciatore M. Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H2-receptor antagonist activity in gastric fistula cat. Agents Actions. 1989 Apr;27(1-2):192-4.</citation>
    <PMID>2568739</PMID>
  </reference>
  <reference>
    <citation>Carlowe J. Investigation into home care of elderly people shows cases of &quot;serious neglect&quot;. BMJ. 2011 Jun 21;342:d3904. doi: 10.1136/bmj.d3904.</citation>
    <PMID>21693536</PMID>
  </reference>
  <reference>
    <citation>S. A. Helekar and H. U. Voss,</citation>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Methodist Hospital System</investigator_affiliation>
    <investigator_full_name>David Chiu, MD</investigator_full_name>
    <investigator_title>Principal Investigator/Sponsor-Investigator</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

